DeepMed Research

Peking University First Hospital (Peking Univesity First Medical School)

🇨🇳China

Country: 🇨🇳China

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Optimization of Management for Sporadic Bilateral Renal Cell Carcinoma

Completed

Conditions: Kidney Cancer

Interventions: Procedure: Surgery treatment or local tumor destruction.

First Posted Date: 2024-04-17

Last Posted Date: 2024-04-17

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 3677

Registration Number: NCT06369519

Locations: 🇨🇳
Peking University First Hospital, Beijing, Beijing, China

Comparison of MRI AI-cTB Versus Routine cTB in Prostate Cancer Diagnosis: a Prospective Randomized Controlled Trial

Not Applicable

Completed

Conditions: Prostate Cancer

Interventions: Procedure: Routine cognitive prostate targeted biopsy
Procedure: MRI-AI guided cognitive prostate targeted biopsy

First Posted Date: 2024-04-12

Last Posted Date: 2024-11-20

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 380

Registration Number: NCT06362291

Locations: 🇨🇳
Peking University First Hospital, Beijing, Beijing, China

Adjuvant Rezvilutamide in Combination With Androgen Deprivation Therapy in Androgen Receptor-positive, High-risk Salivary Duct Carcinoma

Phase 2

Recruiting

Conditions: Salivary Gland Neoplasm Duct

Interventions: Drug: Rezvilutamide
Drug: Leuprolide Acetate

First Posted Date: 2024-04-04

Last Posted Date: 2024-04-04

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 37

Registration Number: NCT06348264

Locations: 🇨🇳
Peking University School and Hospital of Stomatology, Beijing, Beijing, China
🇨🇳
Peking University First Hospital, Beijing, Beijing, China

A Multicenter, Prospective Cohort Study of Preserved Ratio Impaired Spirometry(PRISm) in a Population

Recruiting

Conditions: COPD

First Posted Date: 2024-04-01

Last Posted Date: 2024-04-01

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 2000

Registration Number: NCT06340295

Locations: 🇨🇳
The First Hospital of Qinhuangdao, Qinhuangdao, Hebei, China
🇨🇳
Tianjin Medical University General Hospital, Tianjin, Tianjin, China
🇨🇳
Shandong Provincial Hospital Affiliated to Shandong University, Jing'an, China

and more 2 locations

Fuzheng Nizeng Formula for Chronic Atrophic Gastritis With Low-grade Intraepithelial Neoplasia, a Multicenter Randomized Controlled Trial

Not Applicable

Recruiting

Conditions: Atrophic Gastritis With Low-grade Intraepithelial Neoplasia

Interventions: Drug: Moluodan granules
Drug: Fuzhegn Nizeng Decoction

First Posted Date: 2024-03-22

Last Posted Date: 2024-03-22

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 144

Registration Number: NCT06324825

Locations: 🇨🇳
Peking University First Hospital, Beijing, Beijing, China

Fruquintinib Plus Everolimus as 2nd Line Therapy of ccRCC Patients Progressed Post IO and TKI Therapy

Not Applicable

Recruiting

Conditions: Renal Cell Carcinoma, Clear Cell, Somatic

Interventions: Drug: Fruquintinib and Everolimus

First Posted Date: 2024-03-19

Last Posted Date: 2024-03-19

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 36

Registration Number: NCT06317298

Locations: 🇨🇳
Peking University First Hospital, Beijing, China

PET Imaging of 68Ga-Her2-affibody in Tumors with High Her2 Expression

Not Applicable

Recruiting

Conditions: Neoplasms

Interventions: Drug: 68Ga-Her2-affibody

First Posted Date: 2024-03-04

Last Posted Date: 2024-12-18

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 30

Registration Number: NCT06289517

Locations: 🇨🇳
Peking University First Hospital, Beijing, Beijing, China

Effects of Intraoperative Targeted Temperature Management on Incidence of Postoperative Delirium and Long-term Survival

Not Applicable

Recruiting

Conditions: Hypothermia
Delirium
Long-term Survivors
Cancer Surgery

Interventions: Other: Routine thermal management
Other: Target temperature management

First Posted Date: 2024-02-13

Last Posted Date: 2024-06-10

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 3992

Registration Number: NCT06256354

Locations: 🇨🇳
Peking Union Medical College Hospital, Beijing, Beijing, China
🇨🇳
Xiyuan Hospital of CACMS（China Academy of Chinese Medical Sciences, Beijing, Beijing, China
🇨🇳
Peking University Shenzhen Hospital, Shenzhen, Guangdong, China

and more 18 locations

The Effect of Potassium Lowering Drugs on Cardiac Electrical Stability in Hemodialysis Patients (ART Study)

Phase 4

Recruiting

Conditions: Potassium Imbalance
Cardiac Arrhythmia
Dialysis; Complications

Interventions: Drug: sodium zirconium cyclic silicate

First Posted Date: 2024-02-05

Last Posted Date: 2024-02-05

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 61

Registration Number: NCT06242041

Locations: 🇨🇳
Peking University first hospital hemodialysis center, Beijing, Beijing, China

Liposomal vs. Conventional Bupivacaine for Pain Control

Phase 4

Recruiting

Conditions: Regional Block
Paravertebral Block
Local Anesthetics
Analgesia

Interventions: Drug: Performing paravertebral nerve block with bupivacaine
Drug: Performing paravertebral nerve block with lipo-bupivacaine

First Posted Date: 2024-01-30

Last Posted Date: 2024-04-03

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 60

Registration Number: NCT06231355

Locations: 🇨🇳
Peking University First Hospital, Beijing, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy